Methylphenidate, including its extended-release formulations such as Concerta, is associated with stomach pain as a very common adverse reaction.
Adverse reactions of methylphenidate
- Methylphenidate hydrochloride PO: Abdominal pain is a very common adverse reaction, occurring in over 10% of patients
- Methylphenidate hydrochloride ER PO: Abdominal pain is also a very common adverse reaction for extended-release oral formulations, such as Jornay PM, Metadate CD, Relexxii, Ritalin LA, and QuilliChew ER
- Methylphenidate hydrochloride ER TD: Abdominal pain is a very common adverse reaction for transdermal extended-release formulations, such as Cotempla XR-ODT, Aptensio XR, and Daytrana
In conclusion, abdominal pain is a very common adverse reaction associated with the use of methylphenidate, including its extended-release formulations.